Literature DB >> 28213371

Polygenic risk scores in familial Alzheimer disease.

Giuseppe Tosto1, Thomas D Bird1, Debby Tsuang1, David A Bennett1, Bradley F Boeve1, Carlos Cruchaga1, Kelley Faber1, Tatiana M Foroud1, Martin Farlow1, Alison M Goate1, Sarah Bertlesen1, Neill R Graff-Radford1, Martin Medrano1, Rafael Lantigua1, Jennifer Manly1, Ruth Ottman1, Roger Rosenberg1, Daniel J Schaid1, Nicole Schupf1, Yaakov Stern1, Robert A Sweet1, Richard Mayeux2.   

Abstract

OBJECTIVE: To investigate the association between a genetic risk score (GRS) and familial late-onset Alzheimer disease (LOAD) and its predictive value in families multiply affected by the disease.
METHODS: Using data from the National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease (National Institute on Aging-Late-Onset Alzheimer's Disease Family Study), mixed regression models tested the association of familial LOAD with a GRS based on single nucleotide polymorphisms (SNPs) previously associated with LOAD. We modeled associations using unweighted and weighted scores with estimates derived from the literature. In secondary models, we adjusted subsequent models for presence of the APOE ε4 allele and further tested the interaction between APOE ε4 and the GRS. We constructed a similar GRS in a cohort of Caribbean Hispanic families multiply affected by LOAD by selecting the SNP with the strongest p value within the same regions.
RESULTS: In the NIA-LOAD families, the GRS was significantly associated with LOAD (odds ratio [OR] 1.29; 95% confidence interval 1.21-1.37). The results did not change after adjusting for APOE ε4. In Caribbean Hispanic families, the GRS also significantly predicted LOAD (OR 1.73; 1.57-1.93). Higher scores were associated with lower age at onset in both cohorts.
CONCLUSIONS: High GRS increases the risk of familial LOAD and lowers the age at onset, regardless of ethnic group.
© 2017 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28213371      PMCID: PMC5373783          DOI: 10.1212/WNL.0000000000003734

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

1.  Why significant variables aren't automatically good predictors.

Authors:  Adeline Lo; Herman Chernoff; Tian Zheng; Shaw-Hwa Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-26       Impact factor: 11.205

2.  GenABEL: an R library for genome-wide association analysis.

Authors:  Yurii S Aulchenko; Stephan Ripke; Aaron Isaacs; Cornelia M van Duijn
Journal:  Bioinformatics       Date:  2007-03-23       Impact factor: 6.937

3.  A new explained-variance based genetic risk score for predictive modeling of disease risk.

Authors:  Ronglin Che; Alison A Motsinger-Reif
Journal:  Stat Appl Genet Mol Biol       Date:  2012-09-25

4.  A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42.

Authors:  Kristel Sleegers; Karolien Bettens; Arne De Roeck; Caroline Van Cauwenberghe; Elise Cuyvers; Jan Verheijen; Hanne Struyfs; Jasper Van Dongen; Steven Vermeulen; Sebastiaan Engelborghs; Mathieu Vandenbulcke; Rik Vandenberghe; Peter Paul De Deyn; Christine Van Broeckhoven
Journal:  Alzheimers Dement       Date:  2015-06-15       Impact factor: 21.566

5.  Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.

Authors:  Vincent Chouraki; Christiane Reitz; Fleur Maury; Joshua C Bis; Celine Bellenguez; Lei Yu; Johanna Jakobsdottir; Shubhabrata Mukherjee; Hieab H Adams; Seung Hoan Choi; Eric B Larson; Annette Fitzpatrick; Andre G Uitterlinden; Philip L de Jager; Albert Hofman; Vilmundur Gudnason; Badri Vardarajan; Carla Ibrahim-Verbaas; Sven J van der Lee; Oscar Lopez; Jean-François Dartigues; Claudine Berr; Philippe Amouyel; David A Bennett; Cornelia van Duijn; Anita L DeStefano; Lenore J Launer; M Arfan Ikram; Paul K Crane; Jean-Charles Lambert; Richard Mayeux; Sudha Seshadri
Journal:  J Alzheimers Dis       Date:  2016-06-18       Impact factor: 4.472

6.  Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.

Authors:  A J Slooter; M Cruts; S Kalmijn; A Hofman; M M Breteler; C Van Broeckhoven; C M van Duijn
Journal:  Arch Neurol       Date:  1998-07

7.  Common polygenic variation enhances risk prediction for Alzheimer's disease.

Authors:  Valentina Escott-Price; Rebecca Sims; Christian Bannister; Denise Harold; Maria Vronskaya; Elisa Majounie; Nandini Badarinarayan; Kevin Morgan; Peter Passmore; Clive Holmes; John Powell; Carol Brayne; Michael Gill; Simon Mead; Alison Goate; Carlos Cruchaga; Jean-Charles Lambert; Cornelia van Duijn; Wolfgang Maier; Alfredo Ramirez; Peter Holmans; Lesley Jones; John Hardy; Sudha Seshadri; Gerard D Schellenberg; Philippe Amouyel; Julie Williams
Journal:  Brain       Date:  2015-10-21       Impact factor: 13.501

8.  Coding mutations in SORL1 and Alzheimer disease.

Authors:  Badri N Vardarajan; Yalun Zhang; Joseph H Lee; Rong Cheng; Christopher Bohm; Mahdi Ghani; Christiane Reitz; Dolly Reyes-Dumeyer; Yufeng Shen; Ekaterina Rogaeva; Peter St George-Hyslop; Richard Mayeux
Journal:  Ann Neurol       Date:  2015-02       Impact factor: 10.422

9.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

10.  Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.

Authors:  A Lacour; A Espinosa; E Louwersheimer; S Heilmann; I Hernández; S Wolfsgruber; V Fernández; H Wagner; M Rosende-Roca; A Mauleón; S Moreno-Grau; L Vargas; Y A L Pijnenburg; T Koene; O Rodríguez-Gómez; G Ortega; S Ruiz; H Holstege; O Sotolongo-Grau; J Kornhuber; O Peters; L Frölich; M Hüll; E Rüther; J Wiltfang; M Scherer; S Riedel-Heller; M Alegret; M M Nöthen; P Scheltens; M Wagner; L Tárraga; F Jessen; M Boada; W Maier; W M van der Flier; T Becker; A Ramirez; A Ruiz
Journal:  Mol Psychiatry       Date:  2016-03-15       Impact factor: 15.992

View more
  27 in total

1.  Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families.

Authors:  Padhraig Gormley; Mitja I Kurki; Marjo Eveliina Hiekkala; Kumar Veerapen; Paavo Häppölä; Adele A Mitchell; Dennis Lal; Priit Palta; Ida Surakka; Mari Anneli Kaunisto; Eija Hämäläinen; Salli Vepsäläinen; Hannele Havanka; Hanna Harno; Matti Ilmavirta; Markku Nissilä; Erkki Säkö; Marja-Liisa Sumelahti; Jarmo Liukkonen; Matti Sillanpää; Liisa Metsähonkala; Seppo Koskinen; Terho Lehtimäki; Olli Raitakari; Minna Männikkö; Caroline Ran; Andrea Carmine Belin; Pekka Jousilahti; Verneri Anttila; Veikko Salomaa; Ville Artto; Markus Färkkilä; Heiko Runz; Mark J Daly; Benjamin M Neale; Samuli Ripatti; Mikko Kallela; Maija Wessman; Aarno Palotie
Journal:  Neuron       Date:  2018-05-03       Impact factor: 17.173

2.  A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.

Authors:  Chunyu Zhang; Riletemuer Hu; Guohua Zhang; Yan Zhe; Baolige Hu; Juan He; Zhiguang Wang; Xiaokun Qi
Journal:  J Mol Neurosci       Date:  2019-07-25       Impact factor: 3.444

3.  Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms.

Authors:  Carlos Cruchaga; Jorge L Del-Aguila; Benjamin Saef; Kathleen Black; Maria Victoria Fernandez; John Budde; Laura Ibanez; Yuetiva Deming; Manav Kapoor; Giuseppe Tosto; Richard P Mayeux; David M Holtzman; Anne M Fagan; John C Morris; Randall J Bateman; Alison M Goate; Oscar Harari
Journal:  Alzheimers Dement       Date:  2017-09-21       Impact factor: 21.566

4.  A multivariate model of time to conversion from mild cognitive impairment to Alzheimer's disease.

Authors:  María Eugenia López; Agustín Turrero; Pablo Cuesta; Inmaculada Concepción Rodríguez-Rojo; Ana Barabash; Alberto Marcos; Fernando Maestú; Alberto Fernández
Journal:  Geroscience       Date:  2020-09-04       Impact factor: 7.713

Review 5.  Genetics of Alzheimer's Disease: the Importance of Polygenic and Epistatic Components.

Authors:  Neha Raghavan; Giuseppe Tosto
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-21       Impact factor: 5.081

Review 6.  A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.

Authors:  AmanPreet Badhwar; G Peggy McFall; Shraddha Sapkota; Sandra E Black; Howard Chertkow; Simon Duchesne; Mario Masellis; Liang Li; Roger A Dixon; Pierre Bellec
Journal:  Brain       Date:  2020-05-01       Impact factor: 13.501

Review 7.  Progress in Polygenic Composite Scores in Alzheimer's and Other Complex Diseases.

Authors:  Danai Chasioti; Jingwen Yan; Kwangsik Nho; Andrew J Saykin
Journal:  Trends Genet       Date:  2019-03-25       Impact factor: 11.639

8.  Polygenic Risk Score for Alzheimer's Disease in Caribbean Hispanics.

Authors:  Richard Mayeux; Giuseppe Tosto; Sanjeev Sariya; Daniel Felsky; Dolly Reyes-Dumeyer; Ricky Lali; Rafael A Lantigua; Badri Vardarajan; Ivonne Z Jiménez-Velázquez; Jonathan L Haines; Gerard D Shellenberg; Margaret A Pericak-Vance; Guillaume Paré
Journal:  Ann Neurol       Date:  2021-06-17       Impact factor: 11.274

9.  Systematic Review: Genetic, Neuroimaging, and Fluids Biomarkers for Frontotemporal Dementia Across Latin America Countries.

Authors:  Claudia Duran-Aniotz; Paulina Orellana; Tomas Leon Rodriguez; Fernando Henriquez; Victoria Cabello; María F Aguirre-Pinto; Tamara Escobedo; Leonel T Takada; Stefanie D Pina-Escudero; Oscar Lopez; Jennifer S Yokoyama; Agustin Ibanez; Mario A Parra; Andrea Slachevsky
Journal:  Front Neurol       Date:  2021-06-24       Impact factor: 4.003

Review 10.  Predictive Genetic Counseling for Neurodegenerative Diseases: Past, Present, and Future.

Authors:  Jill S Goldman
Journal:  Cold Spring Harb Perspect Med       Date:  2020-07-01       Impact factor: 5.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.